Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chronic obstructive pulmonary disease in sub-Saharan Africa.
Awokola BI, Amusa GA, Jewell CP, Okello G, Stobrink M, Finney LJ, Mohammed N, Erhart A, Mortimer KJ. Awokola BI, et al. Among authors: finney lj. Int J Tuberc Lung Dis. 2022 Mar 1;26(3):232-242. doi: 10.5588/ijtld.21.0394. Int J Tuberc Lung Dis. 2022. PMID: 35197163 Free PMC article.
Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
Mallia P, Webber J, Gill SK, Trujillo-Torralbo MB, Calderazzo MA, Finney L, Bakhsoliani E, Farne H, Singanayagam A, Footitt J, Hewitt R, Kebadze T, Aniscenko J, Padmanaban V, Molyneaux PL, Adcock IM, Barnes PJ, Ito K, Elkin SL, Kon OM, Cookson WO, Moffat MF, Johnston SL, Tregoning JS. Mallia P, et al. J Allergy Clin Immunol. 2018 Sep;142(3):815-823.e6. doi: 10.1016/j.jaci.2017.10.017. Epub 2018 Jan 5. J Allergy Clin Immunol. 2018. PMID: 29310905 Free PMC article.
Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial.
Ritchie AI, Brill SE, Vlies BH, Finney LJ, Allinson JP, Alves-Moreira L, Wiseman DJ, Walker PP, Baker E, Elkin SL, Mallia P, Law M, Donaldson GC, Calverley PMA, Wedzicha JA. Ritchie AI, et al. Among authors: finney lj. Am J Respir Crit Care Med. 2020 Aug 15;202(4):549-557. doi: 10.1164/rccm.201910-2058OC. Am J Respir Crit Care Med. 2020. PMID: 32267724 Free PMC article. Clinical Trial.
Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations.
Calderazzo MA, Trujillo-Torralbo MB, Finney LJ, Singanayagam A, Bakhsoliani E, Padmanaban V, Kebadze T, Aniscenko J, Elkin SL, Johnston SL, Mallia P. Calderazzo MA, et al. Among authors: finney lj. Int J Chron Obstruct Pulmon Dis. 2019 Apr 10;14:823-832. doi: 10.2147/COPD.S191946. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31114182 Free PMC article.
Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease.
Singanayagam A, Glanville N, Cuthbertson L, Bartlett NW, Finney LJ, Turek E, Bakhsoliani E, Calderazzo MA, Trujillo-Torralbo MB, Footitt J, James PL, Fenwick P, Kemp SV, Clarke TB, Wedzicha JA, Edwards MR, Moffatt M, Cookson WO, Mallia P, Johnston SL. Singanayagam A, et al. Among authors: finney lj. Sci Transl Med. 2019 Aug 28;11(507):eaav3879. doi: 10.1126/scitranslmed.aav3879. Sci Transl Med. 2019. PMID: 31462509 Free PMC article.
Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease.
Singanayagam A, Footitt J, Marczynski M, Radicioni G, Cross MT, Finney LJ, Trujillo-Torralbo MB, Calderazzo M, Zhu J, Aniscenko J, Clarke TB, Molyneaux PL, Bartlett NW, Moffatt MF, Cookson WO, Wedzicha J, Evans CM, Boucher RC, Kesimer M, Lieleg O, Mallia P, Johnston SL. Singanayagam A, et al. Among authors: finney lj. J Clin Invest. 2022 Apr 15;132(8):e120901. doi: 10.1172/JCI120901. J Clin Invest. 2022. PMID: 35239513 Free PMC article.
33 results